Clinical Trial Update: Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada

View source ↗

Summary

This clinical trial update examines the impact of introducing the pneumococcal vaccine PHiD-CV (Synflorix) for Nunavik children. It covers outcomes related to a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Lower Respiratory Tract Infection
• Otitis Media
• Upper Respiratory Infection

Drugs mentioned

• Synflorix (PHiD-CV) (pneumococcal 10-valent conjugate vaccine)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Acute Upper Respiratory Infection, Acute Lower Respiratory Tract Infection | Status: UNKNOWN